What is TelyRx?
TelyRx operates as a digital health platform, specializing in providing affordable online prescriptions and rapid delivery services to a substantial patient base exceeding 200,000 individuals nationwide. The company streamlines access to a broad spectrum of medications, addressing needs from chronic conditions and mental health to everyday lifestyle requirements. By facilitating remote consultations with licensed providers and enabling discreet home delivery through partner pharmacies, TelyRx effectively removes the necessity for in-person medical visits, thereby enhancing patient convenience and care accessibility.
How much funding has TelyRx raised?
TelyRx has raised a total of $12.6M across 1 funding round:
Private Equity
$12.6M
Private Equity (2026): $12.6M, investors not publicly disclosed
What's next for TelyRx?
The substantial enterprise-level backing TelyRx has garnered signals a strategic pivot towards aggressive scaling and market expansion. This significant capital infusion is likely to be deployed in enhancing technological infrastructure, broadening the network of healthcare providers and pharmacies, and potentially exploring new therapeutic areas or service lines. The company's focus on patient-centric care and digital accessibility positions it for continued growth in the evolving telehealth landscape, aiming to solidify its standing as a leader in online pharmaceutical services.
See full TelyRx company page
